Utilization Analysis of Carbapenems in 34 Hospitals of Wuhan Area during 2007-2014
- VernacularTitle:武汉地区34家医院2007~2014年碳青霉烯类药物应用情况分析
- Author:
Sisi LIAO
;
Ying LUO
;
Xiping LI
- Keywords:
Carbapenems;
Defined daily dose;
DDDs;
Daily drug cost;
Drug utilization analysis
- From:
China Pharmacist
2017;20(6):1083-1086
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To investigate the application and tendency of carbapenems in the hospitals of Wuhan area.Methods: The application of carbapenems in 34 hospitals of Wuhan area during 2007-2014 was analyzed statistically in terms of consumption sum, DDDs, DDC and so on.Results: The total consumption sum of carbapenems increased year by year.Compared with that in 2007, the total consumption sum increased by 4-fold in 2014.The growing rate of total consumption sum of biapenem was the fastest among various varieties.Since 2009, three injections including meropenem, biapenem and imipenem / cilastatin predominated the market of Wuhan area, followed by faropenem with oral administration.The changing trend of DDDs was basically consistent with the total consumption sum.DDC of all the drugs was relatively high and demonstrated decreasing tendency, and that of biapenem decreased most notably, while still ranked the first place.DDC of meropenem and imipenem/cilastatin both exceeded 400 yuan.The price of faropenem fluctuated notably during 2007-2009, while increased by 2-fold in 2009 (453 yuan) and then remained stable.Conclusion: The special rectification measures show positive impact on the selection of antimicrobial agents in Wuhan area.The drug varieties are proper, while the average daily cost is still high.The government should continue to strengthen the management of antibiotics to ensure the rational use of carbapenems.
